Peripheral levels of selected adipokines in patients with newly diagnosed multiple sclerosis.
Agnieszka Baranowska-BikDorota UchmanAnna LitwiniukMałgorzata KaliszLidia MartyńskaBogusława BaranowskaWojciech BikJan KochanowskiPublished in: Endokrynologia Polska (2020)
Our results indicate that adiponectin with its fractions, visfatin, and omentin cannot be considered as causative factors in the early phase of multiple sclerosis. However, the potential role of adipokines in MS is possible because they might be involved in the pathogenesis of MS, regarded as an autoimmune disorder.